Skip to content
Screener

Innoviva, Inc. INVA Total Current Liabilities

Total Current Liabilities at other companies

Pfizer logo
PfizerPFE
$34.35B-5.8%
Merck & Co. logo
Merck & Co.MRK
$27.73B+6.5%
AbbVie logo
AbbVieABBV
$42.1B+15.6%
Insmed logo
InsmedINSM
$438.74M+40.8%
Savara logo
SavaraSVRA
$15.54M+30.6%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$25M+93.0%

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.53B+33.1%
Enterprise value$1.22B+2.1%
P/E4.3×-25.4×
P/S3.5×+0.4×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235
Line itemJune 30, 2026 / (Unaudited)December 31, 2025 / *
Deferred revenue6,0154,270
Income tax payable274
Other accrued liabilities28,61329,468
Total current liabilities47,06449,696
Long-term debt, net of discount and issuance costs258,454257,731
Other long-term liabilities67,27666,091
Deferred tax liabilities, net36,73931,793
Income tax payable, long-term59,93257,013

Item 1. Financial Statements

FAQ

What is Innoviva, Inc.'s total current liabilities?
Innoviva, Inc. (INVA) reported total current liabilities of $47.06M in Q2 2026.
How has Innoviva, Inc.'s total current liabilities changed year-over-year?
Innoviva, Inc.'s total current liabilities decreased by 80.9% year-over-year, from $246.56M to $47.06M.
What is the long-term trend for Innoviva, Inc.'s total current liabilities?
Over 5 years (2020 to 2025), Innoviva, Inc.'s total current liabilities has grown at a 52.1% compound annual growth rate (CAGR), from $6.11M to $49.7M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Innoviva, Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude